Abstract:ObjectiveTo understand detection results and difference in multidrugresistant organisms (MDROs) in intensive care unit (ICU) and nonICU. MethodsStrains isolated from clinical specimens of hospitalized patients in a hospital from January 2015 to December 2016 were analyzed, 6 kinds of MDROs were conducted targeted monitoring, isolation and antimicrobial resistance of 6 kinds of MDROs from ICU and nonICU patients were compared. ResultsA total of 1 013 strains of 6 kinds of MDROs were monitored, isolation rate was13.13%. Isolation rate of MDROs in ICU was higher than that of nonICU (24.60% vs 5.47%, P<0.001). Carbapenemresistant Acinetobacter baumannii(CRAB) was the main isolated MDROs, accounting for 69.40%;of different pathogenic organisms, isolation rate of CRAB was the highest (55.75%). The main MDROs detected in ICU and nonICU were both CRAB, accounting for 76.32% and 48.62% respectively; Of isolated pathogens, isolation rate of MDROs in ICU was higher than that of nonICU (47.95% vs 8.02%, P<0.001). Antimicrobial resistance rates of Escherichia coli isolated from ICU to ticarcillin/clavulanic acid, ceftriaxone, cefotaxime, cefepime, imipenem, meropenem, amikacin, and gentamicin were all higher than that of nonICU, resistant to piperacillin was lower than nonICU, difference was statistically significant (all P≤0.05); resistance rates of Klebsiella pneumoniae from ICU to common antimicrobial agents (except piperacillin ) were all higher than nonICU(all P<0.05). Resistance rates of Acinetobacter baumannii and Pseudomonas aeruginosa from ICU to common antimicrobial agents were all higher than nonICU (all P<0.05). Resistance rates of Staphylococcus aureus isolated from ICU to oxacillin, ciprofloxacin, tetracycline, and rifampicin were all higher than nonICU (all P<0.05), and resistance rates of Enterococcus faecium to quinupristin/dafoeleptin and tetracycline were both lower than nonICU (both P<0.05). ConclusionIsolation rate of MDROs in ICU is high, resistance rates to most antimicrobial agents are also higher than nonICU, monitoring on MDROs in ICU should be strengthened, and according prevention and control measures should be formulated.